Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center’s retrospective analysis

  • 259 Accesses

  • 4 Citations

Abstract

Purpose

To evaluate the role of two different approaches to perform laparoscopic RPLND: transperitoneal laparoscopic retroperitoneal lymph node dissection (TL-RPLND) and extraperitoneal laparoscopic retroperitoneal lymph node dissection (EL-RPLND).

Materials and methods

Between February 2003 and April 2013, 39 patients with nonseminomatous germ cell testicular tumors were treated by RPLND in our center. Twenty-one patients had TL-RPLND, and 18 patients had EL-RPLND. We performed a comprehensive retrospective study comparing TL-RPLND and EL-RPLND. Certain parameters, including operative time, estimated blood loss, perioperative complications, resected lymph nodes, postoperative intestinal function recovery time, ejaculation, and postoperative tumor markers, were abstracted and compared.

Results

In the EL-RPLND and TL-RPLND groups, the operation times were 178 ± 31 and 207 ± 25 min; the amounts of estimated blood loss were 87 ± 26 and 111 ± 21 ml; the postoperative intestinal function recovery times were 1.2 ± 0.7 and 2.4 ± 0.6 days; the postoperative hospital stays were 5.8 ± 1.1 and 5.5 ± 1.4 days; and the numbers of resected lymph nodes were 16.2 ± 1.5 and 15.8 ± 1.6, respectively. No conversion from laparoscopic to open surgery occurred. No patient in either group received an intraoperative blood transfusion. Overall, two patients developed postoperative fever, and one developed abdominal distension. After a median follow-up of 45 months, no regional relapse or metastases occurred, but 4 patients at clinical stage II were treated successfully by three cycles of platinum-based postoperative chemotherapy. Currently, all patients show no evidence of disease.

Conclusion

Our results demonstrate that EL-RPLND was superior to the transperitoneal approach in terms of the operation time, estimated blood loss, and postoperative intestinal function recovery time, whereas no differences were observed in the number of lymph nodes resected. EL-RPLND was demonstrated to be safe and feasible, with satisfactory clinical outcomes when performed by experienced laparoscopic surgeons. Larger cohorts of patients with longer term follow-up are needed for further studies to determine the role of different approaches to L-RPLND.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Hayes-Lattin B, Nichols CR (2009) Testicular cancer: a prototypic tumor of young adults. Semin Oncol 36(5):432–438

  2. 2.

    Yuvaraja TB (2012) Current update of management of clinical stage I non seminomatous germ cell tumors of testis. Indian J Surg Oncol 3(2):101–106

  3. 3.

    LeBlanc E, Caty A et al (2001) Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results. J Urol 165(1):89–92

  4. 4.

    Skolarus TA, Bhayani SB et al (2008) Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer. J Endourol 22(7):1485–1489

  5. 5.

    LeBlanc A, Caty A, Dargent D et al (2001) Extraperitoneal laparoscopic para-aortic lymph node dissection for early stage nonseminomatous germ cell tumors of the testis with introduction of a nerve sparing technique: description and results. J Urol 165:89–92

  6. 6.

    Davol P, Sumfest J, Rukstalis D (2006) Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 67:199

  7. 7.

    Qin C, Meng X et al (2011) Extraperitoneal laparoscopic retroperitoneal lymph node dissection. J Endourol Part B Videourology. doi:10.1089/vid.2010.0094

  8. 8.

    Sesterhenn IA, Davis CJ Jr (2004) Pathology of germ cell tumors of the testis. Cancer Control 11(6):374–387

  9. 9.

    Rukstalis DB, Chodak GW (1992) Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol 148(6):1907-9; discussion 1909-10

  10. 10.

    Suer E, Mermerkaya M et al (2013) Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor? J Urol. http://dx.doi.org/10.1016/j.juro.2013.06.009, http://www.sciencedirect.com/science/article/pii/S0022534713045722. ISSN 0022-5347

  11. 11.

    Heinzelbecker J, Katzmarzik M et al (2013) During twenty years of Cisplatin-based therapy the face of nonseminomatous testicular germ cell tumors is still changing: an evaluation of presentation, management, predictive factors and survival. Int Braz J Urol 39(1):10–21

  12. 12.

    Oldenburg J, Alfsen GC, Lien HH et al (2003) Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 21(17):3310–3317

  13. 13.

    Foster R, Bihrle R (2002) Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate. Cancer Control 9(4):277–283

  14. 14.

    Ozen H, Ekici S et al (2001) Resection of residual masses alone: an alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy. Urology 57(2):323–327

  15. 15.

    Lv ZJ, Wu S et al (2013) Clinical outcomes in patients with stage I non-seminomatous germ cell cancer. Asian J Androl 15(4):558–563

  16. 16.

    Heidenreich A, Pfister D (2012) Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice. Ther Adv Urol 4(4):187–205

  17. 17.

    Dash A, Carver BS et al (2008) The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor. Cancer 112(4):800–805

  18. 18.

    Nonomura N, Nishimura K et al (2002) Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy. Int J Urol 9(10):539–544

  19. 19.

    Liu ZW et al (2008) Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors. Ai Zheng 27(12):1302–1306

  20. 20.

    Carver BS et al (2010) The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer. Urology 75(6):1431–1435

  21. 21.

    Hudolin T et al (2012) Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors. Int J Surg Pathol 20(1):15–18

  22. 22.

    Arai Y, Kaiho Y et al (2012) Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes. Int Urol Nephrol 44(5):1389–1395

  23. 23.

    Sherwood JB et al (2003) Laparoscopic retroperitoneal lymph node dissection in the extremely obese patient: technical insight into access and port placement. JSLS 7(3):265–267

  24. 24.

    Albers P et al (2012) EAU guidelines on testicular cancer: 2011 update. European Association of Urology. Actas Urol Esp 36(3):127–145

  25. 25.

    Djaladat H, Nichols C et al (2012) Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Ann Surg Oncol 19(7):2388–2393

  26. 26.

    Lattouf JB, Jeschke S et al (2007) Laparoscopic retroperitoneal lymph node dissection: technique. BJU Int 100(6):1415–1429

Download references

Conflict of interest

We declare that we have no financial and personal relationships with other people or organizations that can inappropriately influence our work, and there is no professional or other personal interest of any nature or kind in any product, service, and/or company that could be construed as influencing the position presented in the manuscript.

Author information

Correspondence to Lin Qi.

Additional information

Minfeng Chen contributed equally to this work with Shiyu Tong.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tong, S., Chen, M., Zu, X. et al. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center’s retrospective analysis. Int Urol Nephrol 46, 363–369 (2014). https://doi.org/10.1007/s11255-013-0547-3

Download citation

Keywords

  • Transperitoneal retroperitoneal lymph node dissection
  • Extraperitoneal retroperitoneal lymph node dissection
  • Nonseminomatous germ cell testicular tumors